Home » Topics » BioWorld Science

BioWorld Science
RSS

RegenxBio initiates first-in-human trial of RGX-111 for treatment of MPS I

July 17, 2018

Neurotrope initiates enrollment in confirmatory phase II study of bryostatin-1

July 17, 2018

Promising data presented from completed pivotal study of PRO-140 with HAART for HIV-1

July 17, 2018

Concentric Analgesics initiates phase II trial of CA-008 to treat postsurgical pain

July 17, 2018

Rimeporide well tolerated in boys with Duchenne muscular dystrophy

July 17, 2018

Longitudinal study confirms fat, disputes sugar as obesity cause in mice

July 17, 2018

Animal model of HAAF provides insight on pathological process of the disease

July 17, 2018

Novel mouse model of miR-7-induced pancreatic beta-cell dedifferentiation

July 17, 2018

A mosaic HIV-1 vaccine is assessed in a phase I/IIa trial and in rhesus monkeys

July 17, 2018

A designer supramolecule AK-750 amplifies innate immune responses in preclinical models of cancer

July 17, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...